| FDA Panel Backs Use Of Amgen's Aranesp For Kidney Disease Patients - Wall Street Journal |
|
|
Wall Street JournalThe agency's cardiovascular and renal drugs advisory panel is currently meeting to discuss whether the use of Aranesp in patients with kidney disease should ... read more |